MENU
+Compare
SLNO
Stock ticker: NASDAQ
AS OF
Aug 11, 11:52 AM (EDT)
Price
$85.30
Change
+$2.95 (+3.58%)
Capitalization
4.38B

SLNO Soleno Therapeutics Forecast, Technical & Fundamental Analysis

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases... Show more

SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SLNO with price predictions
Aug 08, 2025

SLNO in upward trend: price rose above 50-day moving average on August 08, 2025

SLNO moved above its 50-day moving average on August 08, 2025 date and that indicates a change from a downward trend to an upward trend. In of 41 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SLNO advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .

SLNO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 169 cases where SLNO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SLNO moved out of overbought territory on July 10, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on July 30, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SLNO as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SLNO turned negative on July 25, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SLNO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SLNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (18.215) is normal, around the industry mean (18.662). P/E Ratio (0.000) is within average values for comparable stocks, (54.033). SLNO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.909). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (114.943) is also within normal values, averaging (286.048).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SLNO is expected to report earnings to rise 234.56% to -30 cents per share on November 05

Soleno Therapeutics SLNO Stock Earnings Reports
Q3'25
Est.
$-0.30
Q2'25
Beat
by $0.55
Q1'25
Missed
by $0.06
Q4'24
Missed
by $0.30
Q3'24
Missed
by $1.22
The last earnings report on August 06 showed earnings per share of -9 cents, beating the estimate of -63 cents. With 183.99K shares outstanding, the current market capitalization sits at 4.38B.
A.I. Advisor
published General Information

General Information

a developer of medical diagnostics and therapeutics based on its proprietary technology for precision metering of gas flow

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
203 Redwood Shores Parkway
Phone
+1 650 213-8444
Employees
42
Web
https://www.soleno.life
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CMLEX59.740.27
+0.45%
American Funds American Mutual 529E
TCBIX8.850.03
+0.34%
Covered Bridge I
VVJFX75.350.09
+0.12%
Voya Multi-Manager Intl Sm Cp R6
NRIFX22.28-0.05
-0.22%
Nuveen Real Asset Income R6
FSGAX48.72-0.78
-1.58%
Franklin Small-Mid Cap Growth Adv

SLNO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with SYRE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
+4.62%
SYRE - SLNO
42%
Loosely correlated
N/A
NKTX - SLNO
41%
Loosely correlated
-1.49%
RARE - SLNO
40%
Loosely correlated
-1.04%
CRNX - SLNO
39%
Loosely correlated
-3.69%
RVMD - SLNO
39%
Loosely correlated
+0.17%
More